Piper Sandler & Co’s Exact Sciences EXAS Stock Holding History

Piper Sandler & Co’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-15,000	Closed	-$213K	–	128
2014 Q1	$213K	Buy	+15,000	New	+$203K	0.18%	72

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Piper Sandler & Co's EXAS Position: Q2 2014 in Review

Piper Sandler & Co sold out of Exact Sciences (EXAS) in Q2 2014, closing a stake of 15,000 shares — an estimated $213K sold.

Piper Sandler & Co first reported a position in EXAS in Q1 2014 and held it in 1 quarter. The position peaked at $213K in Q1 2014. 156 funds tracked by Wall St. Rank hold EXAS as of Q2 2014.

Piper Sandler & Co reported no remaining Exact Sciences position as of Q2 2014 after selling out during the quarter.
Piper Sandler & Co sold 15,000 Exact Sciences shares in Q2 2014, an estimated $213K.
Piper Sandler & Co first reported a position in Exact Sciences in Q1 2014 and held it in 1 quarter.
Piper Sandler & Co's Exact Sciences position peaked at $213K in Q1 2014.
156 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2014.

Based on Piper Sandler & Co's 13F filing for Q2 2014, filed 14 Aug 2014.